MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Cilostazol

Cilostazol 50mg tablets

No stability information

Stability notes for Cilostazol 50mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Cilostazol 50mg tablets
Cilostazol 50mg tablets (A A H Pharmaceuticals Ltd)
Cilostazol 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Cilostazol 50mg tablets (CST Pharma Ltd)
Cilostazol 50mg tablets (Medihealth (Northern) Ltd)
Cilostazol 50mg tablets (Sigma Pharmaceuticals Plc)
Cilostazol 50mg tablets (Viatris UK Healthcare Ltd)

Cilostazol 100mg tablets

No stability information

Stability notes for Cilostazol 100mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Cilostazol 100mg tablets
Cilostazol 100mg tablets (A A H Pharmaceuticals Ltd)
Cilostazol 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Cilostazol 100mg tablets (Medihealth (Northern) Ltd)
Cilostazol 100mg tablets (Sigma Pharmaceuticals Plc)
Cilostazol 100mg tablets (Viatris UK Healthcare Ltd)
Pletal 100mg tablets (CST Pharma Ltd)
Pletal 100mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.